Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
urlpharma.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Valuation

$0000 

About URL Pharma

URL Pharma, formerly URL Mutual, is a specialty pharmaceutical company developing and commercializing safe and effective medications and technologies. Its lead product, Colcrys (colchicine), is a prescription medicine used in adults to prevent gout flares and treat gout flares when taken at the first sign of a flare. The company has also developed Uloric, a prescription medicine used to lower blood uric acid levels in adults with gout.In April 2012, URL Pharma was acquired by Takeda Pharmaceuticals. The valuation of URL Pharma was $800 million.

URL Pharma Headquarter Location

1100 Orthodox Street

Philadelphia, Pennsylvania, 19124,

United States

215-697-1900

Latest URL Pharma News

URL Pharma Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Dec 5, 2016

Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » URL Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' URL Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by URL Pharma, Inc. since January 2007. Key Findings Provides intelligence on URL Pharma, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by URL Pharma, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for URL Pharma, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about URL Pharma, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing URL Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

URL Pharma is included in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.